Literature DB >> 2306483

Mycolic acid synthesis by Mycobacterium aurum cell-free extracts.

C Lacave1, M A Lanéelle, G Lanéelle.   

Abstract

The first cell-free system capable of synthesizing whole mycolic acids: (R1CH(OH)CH(R2)COOH, with 60 to 90 carbon atoms) from [1-14C]acetate is described and preliminary investigations into some of its requirements and properties are reported. Biosynthetic activity for mycolic acids occurred in an insoluble fraction (40 000 X g pellet) from disrupted cells of Mycobacterium aurum (ATCC 23366-type strain); it produced mycolic acids, but a very small amount of non-hydroxylated fatty acids. The predominant product was unsaturated mycolic acid (type I), while oxo- (type IV) and dicarboxy- (type VI) mycolic acids were synthesized to a lesser extent. When [1-14C]palmitic acid was used as a marker, no labelled mycolic acid was detected. The reaction required a divalent cation (Mg2+ or Mn2+), KHCO3 and O2. Neither CoA, NADH, NADPH nor ATP were necessary, but CoA rather increased the synthesis of non-hydroxylated fatty acids. Glucose or trehalose were not required. Avidin inhibited the biosynthesis of the three types of mycolic acid indicating the presence of a biotin-requiring enzyme in the reaction sequence and therefore a carboxylation step, but citrate had no allosteric effect. Iodoacetamide inhibited the system. These first data are in favor of a complex multienzyme system.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2306483     DOI: 10.1016/0005-2760(90)90159-u

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  9 in total

1.  Mycobacterium tuberculosis Des protein: an immunodominant target for the humoral response of tuberculous patients.

Authors:  M Jackson; D Portnoï; D Catheline; L Dumail; J Rauzier; P Legrand; B Gicquel
Journal:  Infect Immun       Date:  1997-07       Impact factor: 3.441

2.  A mutant of Mycobacterium smegmatis defective in the biosynthesis of mycolic acids accumulates meromycolates.

Authors:  J Liu; H Nikaido
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-30       Impact factor: 11.205

3.  Antimycobacterial action of thiolactomycin: an inhibitor of fatty acid and mycolic acid synthesis.

Authors:  R A Slayden; R E Lee; J W Armour; A M Cooper; I M Orme; P J Brennan; G S Besra
Journal:  Antimicrob Agents Chemother       Date:  1996-12       Impact factor: 5.191

Review 4.  Antimicrobial agent resistance in mycobacteria: molecular genetic insights.

Authors:  J M Musser
Journal:  Clin Microbiol Rev       Date:  1995-10       Impact factor: 26.132

5.  Determination of the primary target for isoniazid in mycobacterial mycolic acid biosynthesis with Mycobacterium aurum A+.

Authors:  P R Wheeler; P M Anderson
Journal:  Biochem J       Date:  1996-09-01       Impact factor: 3.857

6.  Identification of the apparent carrier in mycolic acid synthesis.

Authors:  G S Besra; T Sievert; R E Lee; R A Slayden; P J Brennan; K Takayama
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-20       Impact factor: 11.205

7.  Ethambutol inhibition of glucose metabolism in mycobacteria: a possible target of the drug.

Authors:  G Silve; P Valero-Guillen; A Quemard; M A Dupont; M Daffe; G Laneelle
Journal:  Antimicrob Agents Chemother       Date:  1993-07       Impact factor: 5.191

8.  Isoniazid inhibition of mycolic acid synthesis by cell extracts of sensitive and resistant strains of Mycobacterium aurum.

Authors:  A Quémard; C Lacave; G Lanéelle
Journal:  Antimicrob Agents Chemother       Date:  1991-06       Impact factor: 5.191

9.  Mycolic acid synthesis: a target for ethionamide in mycobacteria?

Authors:  A Quémard; G Lanéelle; C Lacave
Journal:  Antimicrob Agents Chemother       Date:  1992-06       Impact factor: 5.191

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.